[1]
Kahkashan, I., Chawdhary, S., Tandon, V.R. and Gupta, R. 2019. To compare the efficacy and safety of silodosin and dutasteride combination with alfuzosin and dutasteride combination in patients of benign prostatic hyperplasia: a randomized, open label study. International Journal of Basic & Clinical Pharmacology. 8, 4 (Mar. 2019), 635–641. DOI:https://doi.org/10.18203/2319-2003.ijbcp20191095.